Here’s Why You Should Hold on to STERIS (STE) Stock for Now

Posted byZacks Equity Research Leave a comment on Here’s Why You Should Hold on to STERIS (STE) Stock for Now

Investors are optimistic about STERIS (STE) on its better-than-expected earnings in the fiscal third quarter and the ongoing integration of the Cantel Medical business.

Leave a comment

Your email address will not be published. Required fields are marked *